OWCP
OWC Pharmaceutical Research Corp
Price:  
USD
Volume:  
52,640
Israel | Manufacturing

OWCP WACC - Weighted Average Cost of Capital

The WACC of OWC Pharmaceutical Research Corp (OWCP) is 5.6%.

The Cost of Equity of OWC Pharmaceutical Research Corp (OWCP) is 7.5%.
The Cost of Debt of OWC Pharmaceutical Research Corp (OWCP) is 5%.

RangeSelected
Cost of equity5.8% - 9.2%7.5%
Tax rate26.2% - 27.0%26.6%
Cost of debt5.0% - 5.0%5%
WACC4.8% - 6.4%5.6%
WACC

OWCP WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.430.78
Additional risk adjustments0.0%0.5%
Cost of equity5.8%9.2%
Tax rate26.2%27.0%
Debt/Equity ratio
11
Cost of debt5.0%5.0%
After-tax WACC4.8%6.4%
Selected WACC5.6%

OWCP's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for OWCP:

cost_of_equity (7.50%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.43) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.